Tumor Size Combined With CA-19 Level Improves Prediction of Survival of Patients With Pancreatic Adenocarcinoma Undergoing Perioperative Chemotherapy and Resection.
Sayf A SaidBreanna C PerlmutterChase J WehrleJenny H ChangMir Shanaz HossainSamer NaffoujeDaniel JoyceRobert SimonR Matthew WalshToms AugustinPublished in: The American surgeon (2024)
CA 19-9 in combination with tumor size better identifies patients with prolonged post-resection survival. This prediction is most accurate in patients with either small (≤2 cms) or large (>4 cms) tumors compared to intermediate-size tumors.